Requirements for market entry of gene drive-modified mosquitoes for control of vector-borne diseases: analogies to other biologic and biotechnology products.

James, Stephanie L; Quemada, Hector; Benedict, Mark Q; Dass, Brinda

James, Stephanie L; Quemada, Hector; Benedict, Mark Q; Dass, Brinda.

Afiliação

James SL; GeneConvene Global Collaborative, Foundation for the NIH, Bethesda, MD, United States.
Quemada H; Independent Consultant, Kalamazoo, MI, United States.
Benedict MQ; CDC Foundation, Atlanta, GA, United States.
Dass B; GeneConvene Global Collaborative, Foundation for the NIH, Bethesda, MD, United States.

Front Bioeng Biotechnol ; 11: 1205865, 2023.

Article em En | MEDLINE | ID: mdl-37362219

Palavras-chave

gene drive; genetic modification; malaria; manufacturing standards; market entry; mosquito; regulatory approval; supply chain

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article